There was a significant decline in the expression of PD-L1 in the tumor tissues of CSE-treated mice and an elevation in the expression of PD-L1 in the tumor tissues of mice administrated with CSE + sh-KCTD9 (Fig. 6C). This evidence concerns the gene KCTD9 and neoplasm.